Editorial: proton pump inhibitor use in cirrhosis—a piece of the puzzle-Reference-Cited by-同舟云学术

Editorial: proton pump inhibitor use in cirrhosis—a piece of the puzzle

Published:2021-02-10 Issue:5 Volume:53 Page:663-664
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Celsa Ciro¹²^ORCID,Cammà Calogero¹^ORCID

Affiliation:

1. Section of Gastroenterology & Hepatology Department of Health Promotion, Mother and Child Care Internal Medicine and Medical Specialties PROMISE University of Palermo Palermo Italy

2. Department of Surgical, Oncological and Oral Sciences (Di.Chir.On.S.) University of Palermo Palermo Italy

Abstract

LINKED CONTENTThis article is linked to Rocco et al papers. To view these articles, visit https://doi.org/10.1111/apt.16239 and https://doi.org/10.1111/apt.16254

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.16250

Reference10 articles.

1. Review article: prescribing medications in patients with cirrhosis - a practical guide

2. Pharmacokinetics and Pharmacodynamics of the Proton Pump Inhibitors

3. Prevalence of Drug Prescriptions and Potential Safety in Patients with Cirrhosis: A Retrospective Real-World Study

4. Proton pump inhibitors therapy and risk of Clostridium difficile infection: Systematic review and meta-analysis

5. Proton pump inhibitors are associated with a high rate of serious infections in veterans with decompensated cirrhosis

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of proton pump inhibitors in liver diseases and the effects on the liver;Journal of Digestive Diseases;2022-04

2. Effect of a combination of omeprazole and high-dose proton pump inhibitors on the treatment of patients with liver cirrhosis complicated with upper gastrointestinal hemorrhage;Tropical Journal of Pharmaceutical Research;2021-11-20

3. Editorial: proton pump inhibitor use in cirrhosis—a piece of the puzzle. Authors' reply;Alimentary Pharmacology & Therapeutics;2021-02-10